Efficacy and Safety of conventional Synthetic,Biologic,and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis-Interstitial Lung Disease: A Narrative Review
Open accessReview articleFirst published online May, 2021
Efficacy and Safety of conventional Synthetic,Biologic,and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis-Interstitial Lung Disease: A Narrative Review